雌激素及雌激素受体调节剂在癌症研究与治疗中的应用
Estrogens and Estrogen Receptor Modulators in Cancer Research and Therapy.
作者信息
Treeck Oliver
机构信息
Department of Gynecology and Obstetrics I, University Medical Center Regensburg, 93053 Regensburg, Germany.
出版信息
Cancers (Basel). 2023 Aug 29;15(17):4318. doi: 10.3390/cancers15174318.
Abstract
Estrogens affect oncogenesis and tumor progression in a variety of cancer entities [...].
摘要
雌激素在多种癌症类型中影响肿瘤发生和肿瘤进展[……]。
相似文献
1
Estrogens and Estrogen Receptor Modulators in Cancer Research and Therapy.雌激素及雌激素受体调节剂在癌症研究与治疗中的应用
Cancers (Basel). 2023 Aug 29;15(17):4318. doi: 10.3390/cancers15174318.
2
Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.选择性雌激素受体调节剂及结合雌激素/巴多昔芬联合疗法：对乳腺影响的综述
Post Reprod Health. 2015 Sep;21(3):112-21. doi: 10.1177/2053369115599090. Epub 2015 Aug 19.
3
Differential effects of selective estrogen receptor modulators and estrogens on mammary blood flow in the ovine.选择性雌激素受体调节剂和雌激素对绵羊乳腺血流的不同影响。
Am J Obstet Gynecol. 2002 Dec;187(6):1555-60. doi: 10.1067/mob.2002.127600.
4
Estrogen Receptor Signaling in the Immune System.免疫系统中的雌激素受体信号传导
Endocr Rev. 2023 Jan 12;44(1):117-141. doi: 10.1210/endrev/bnac017.
5
Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.雌激素作用的分子机制：选择性配体与受体药理学
J Steroid Biochem Mol Biol. 2000 Nov 30;74(5):279-85. doi: 10.1016/s0960-0760(00)00104-7.
6
Differential effects of estrogen-dependent transactivation vs. transrepression by the estrogen receptor on invasiveness of HER2 overexpressing breast cancer cells.雌激素受体介导的雌激素依赖性反式激活与反式抑制对HER2过表达乳腺癌细胞侵袭性的不同影响。
Biochem Biophys Res Commun. 2015 Feb 13;457(3):404-11. doi: 10.1016/j.bbrc.2015.01.004. Epub 2015 Jan 9.
7
Evolution of the tissue selective estrogen complex (TSEC).组织选择性雌激素复合物（TSEC）的演变。
J Cell Physiol. 2013 Jul;228(7):1423-7. doi: 10.1002/jcp.24324.
8
Effect of estrogens on skin aging and the potential role of selective estrogen receptor modulators.雌激素对皮肤衰老的影响及选择性雌激素受体调节剂的潜在作用。
Climacteric. 2007 Aug;10(4):289-97. doi: 10.1080/13697130701467157.
9
Estrogen and Estrogen Receptor Modulators: Potential Therapeutic Strategies for COVID-19 and Breast Cancer.雌激素和雌激素受体调节剂：COVID-19 和乳腺癌的潜在治疗策略。
Front Endocrinol (Lausanne). 2022 Mar 23;13:829879. doi: 10.3389/fendo.2022.829879. eCollection 2022.
10
[Association of estrogens and selective estrogens receptors modulators: towards a renewal of the hormonal treatment?].[雌激素与选择性雌激素受体调节剂的关联：激素治疗能否迎来新变革？]
Presse Med. 2015 Jul-Aug;44(7-8):805-11. doi: 10.1016/j.lpm.2015.07.003. Epub 2015 Aug 13.
引用本文的文献
1
The Fundamental Role of Oxime and Oxime Ether Moieties in Improving the Physicochemical and Anticancer Properties of Structurally Diverse Scaffolds.肟和肟醚部分在改善结构多样支架的物理化学和抗癌性能方面的基本作用。
Int J Mol Sci. 2023 Nov 28;24(23):16854. doi: 10.3390/ijms242316854.
本文引用的文献
1
Role of Estrogen Receptor β, G-Protein Coupled Estrogen Receptor and Estrogen-Related Receptors in Endometrial and Ovarian Cancer.雌激素受体β、G蛋白偶联雌激素受体及雌激素相关受体在子宫内膜癌和卵巢癌中的作用
Cancers (Basel). 2023 May 20;15(10):2845. doi: 10.3390/cancers15102845.
2
Cannabidiol as a Promising Adjuvant Therapy for Estrogen Receptor-Positive Breast Tumors: Unveiling Its Benefits with Aromatase Inhibitors.大麻二酚作为雌激素受体阳性乳腺肿瘤的一种有前景的辅助治疗方法：揭示其与芳香化酶抑制剂联用的益处
Cancers (Basel). 2023 Apr 27;15(9):2517. doi: 10.3390/cancers15092517.
3
Non-Coding RNAs Modulating Estrogen Signaling and Response to Endocrine Therapy in Breast Cancer.非编码RNA对乳腺癌雌激素信号传导及内分泌治疗反应的调控
Cancers (Basel). 2023 Mar 7;15(6):1632. doi: 10.3390/cancers15061632.
4
Sex- and Female Age-Dependent Differences in Gene Expression in Diffuse Large B-Cell Lymphoma-Possible Estrogen Effects.弥漫性大B细胞淋巴瘤中基因表达的性别及女性年龄依赖性差异——可能的雌激素作用
Cancers (Basel). 2023 Feb 17;15(4):1298. doi: 10.3390/cancers15041298.
5
E3 Ubiquitin Ligase NEDD4 Affects Estrogen Receptor α Expression and the Prognosis of Patients with Hormone Receptor-Positive Breast Cancer.E3泛素连接酶NEDD4影响雌激素受体α表达及激素受体阳性乳腺癌患者的预后。
Cancers (Basel). 2023 Jan 16;15(2):539. doi: 10.3390/cancers15020539.
Zotero 插件